- Filed
- Mar 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 12, 2025 | 200.05M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $204.2M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $230.1M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $649.3M |
| Current Assets | FY 2024 · Dec 31, 2023 | $310.9M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.05B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 69.15M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $10.4M |
| Capex | FY 2024 · Dec 31, 2022 | $1.8M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $175.1M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $0.46 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $0.46 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $145M |
| Operating Income | FY 2024 · Dec 31, 2022 | $179.8M |
| Revenue | FY 2024 · Dec 31, 2022 | $325.9M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2021 | −$121M |